A Pilot Study to Characterize the Immune Response Induced by a Commercial Varicella Zoster Virus Vaccine in Healthy Adult Females in Nairobi, Kenya.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Acronyms KAVI-VZV-001
- 05 Oct 2017 Last checked against ClinicalTrials.gov record.
- 14 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.